India MRSA Infections Drugs Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : April 2021
  • Region: Asia
  • Country: India
  • Report ID : 1363

  • Format: PPT, PDF

Indian MRSA Infections Drugs Market: Segmented by Drugs Type (Oxazolidinones, Glycopeptides, Lipopeptides, Cephalosporin, Tetracycline, Folate Antagonist and Others), by Route of Administration (Oral Administration, Parenteral Administration) by Distribution (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Growth, Trends, and Forecasts (2019 – 2028)

Clear
SKU: 1363 Categories: ,

Report Overview

Indian MRSA Infections Drugs market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.

Methicillin-resistant staphylococcus aureus (MRSA) is an infection caused by antibiotic-resistant strains of the pathogen staphylococcus aureus. Methicillin-resistant Staphylococcus aureus (MRSA) can be divided into two types based on the mode of infection; hospital-associated MRSA infection (HA-MRSA) and community-associated MRSA infections (CA-MRSA). This infection is mainly associated with invasive procedures such as surgeries, intravenous tubing, and sometimes through the skin to skin contact. MRSA drugs are used to kill or restrain Methicillin-resistant staphylococcus aureus infection. Various antibacterial agents such as vancomycin, daptomycin, ceftaroline fosamil, tetracycline, clindamycine, and tedizolid phosphate are available in the market for treatment of infections associated with MRSA.

Market Drivers

Growing incidence of infections associated with Methicillin-resistant staphylococcus aureus (MRSA) pathogens is creating health concerns among the population. Manufacturers are focusing on product development and launches for the treatment of Methicillin-resistant staphylococcus aureus (MRSA), which is expected to boost market growth. Lipopeptide segment accounts for the major market share owing to the novel antibiotic therapy introduced for MRSA. The therapy includes daptomycin, a lipopeptide class of drug and linezolid, an oxazolidinone class of antibiotics. The rapid implementation of therapy is expected to fuel the market growth. Furthermore, the glycopeptides and lipoglycopeptides segment is expected to show significant growth, owing to the increasing focus of manufacturers on the development of advanced drugs in this class.

1. Indian MRSA Infection Drugs Market Overview…………………………………
A. Market Size
2. Market Growth Drivers………………………………………….……………………….
A. Growing Incidence of Infections Associated with Methicillin-Resistant Staphylococcus Aureus (MRSA) Pathogens
B. Increasing Focus of Manufacturers on the Development of Advanced Drugs in this Class.
3. Major Types of MRSA Infection………………………………………….…
A. HA-MRSA
B. CA-MRSA
4. MRSA Infection Drugs Market Segmentation…………………………………
A. By Drug Class
I. Oxazolidinones
II. Glycopeptides
III. Lipopeptides
IV. Cephalosporin
V. Tetracycline
VI. Folate Antagonist
VII. Others.
B. By Route of Administration
I. Oral
II. Parenteral
B. By Distribution Channel
I. Hospital Pharmacy
II. Online Pharmacy
III. Retail Pharmacy
5. MRSA Infection Drugs Major Products Market Share………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Allergan Company, overview, Product & Services, Strategies & Financials
B. Merck & Co. overview, Product & Services, Strategies & Financials
C. Pfizer Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of MRSA Infections Drugs Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drugs Class:

Based on Drug class, the market is segmented into Oxazolidinones, Glycopeptides, Lipopeptides, Cephalosporin, Tetracycline, Folate Antagonist and Others. The glycopeptides (vancomycin) and oxazolidinones (linezolid) are collectively expected to account for over 75% of revenue share in the MRSA treatment market owing to preference of both antibiotic classes as a first-line treatment against MRSA infections and used in more than 80% of MRSA cases treatment.

By Route of Administration:

Based on the route of administration, the market is segmented into oral and parenteral. Parenteral route of administration accounted for highest market share of 72.2% in 2016, due to the increased investment in the pharmaceutical sector by key antibiotics manufacturers to boost the production of intravenous anti-MRSA antibiotics. Oral route of administration is expected to get a boost in terms of revenue by 2025, which is attributable to the key companies involved in the R&D of anti-MRSA vaccines.

By Distribution Channel:

In terms of distribution channels, the market is segmented into Hospital pharmacy, Online Pharmacy and Retail pharmacy. Rise in number of players in the antibiotic manufacturing industry, along with their widespread distribution channels are estimated to propel the market share of the retail pharmacy segment by 2025. Hospital pharmacy is expected to account for a market share of 51.0% by 2025, owing to the increased number of multispecialty hospitals across the globe, and their improved reimbursement policies.

Major Players

India is expected to witness high demand for MRSA testing systems due to high incidences of MRSA infection. India accounts for 4-19% of these infections. The prominent players in the Indian MRSA drugs market are Merck & Co. Inc, Allergan, Baxter, Theravance Biopharma, Pfizer and Novartis.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements